Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01618
|
|||||
| Drug Name |
Benzo(a)pyrene
|
|||||
| Synonyms |
benzo[a]pyrene; 3,4-Benzopyrene; benzo[pqr]tetraphene; BENZO(A)PYRENE; 3,4-Benzpyrene; Benzpyrene; benzo[def]chrysene; 6,7-Benzopyrene; Benz[a]pyrene; 3,4-BP; 3,4-Benz[a]pyrene; 3,4-Benzopirene; 3,4-Benzpyren; Benzo[d,e,f]chrysene; Benz(a)pyrene; (B(a)P); B(a)P; BP; 3,4 Benzpyrene; RCRA waste number U022; Benzo(d,e,f)chrysene; 3,4-Benz(a)pyrene; NSC 21914; 3,4-Benzo(a)pyrene; B[a]p; 3,4-Benzpyren [German]; CCRIS 76; Benzo[A]-Pyrene; Benzo(def)chrysene; 3,4-benzylpyrene; 3,4-Benzopirene [Italian]
|
|||||
| Indication | Environmental exposure [ICD11: NF08.Z] | Phase 1 | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C20H12
|
|||||
| Canonical SMILES |
C1=CC=C2C3=C4C(=CC2=C1)C=CC5=C4C(=CC=C5)C=C3
|
|||||
| InChI |
InChI=1S/C20H12/c1-2-7-17-15(4-1)12-16-9-8-13-5-3-6-14-10-11-18(17)20(16)19(13)14/h1-12H
|
|||||
| InChIKey |
FMMWHPNWAFZXNH-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 50-32-8
|
|||||
| Pharmaceutical Properties | Molecular Weight | 252.3 | Topological Polar Surface Area | 0 | ||
| Heavy Atom Count | 20 | Rotatable Bond Count | 0 | |||
| Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 0 | |||
| XLogP |
6
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
CHEBI:29865
|
|||||
| DT(s) Transporting This Drug | BCRP | Transporter Info | Breast cancer resistance protein | Substrate | [2] | |
| References | ||||||
| 1 | ClinicalTrials.gov (NCT03318978) Benzo[a]Pyrene Ultralow Dose-Response Study | |||||
| 2 | A prediction model of substrates and non-substrates of breast cancer resistance protein (BCRP) developed by GA-CG-SVM method. Comput Biol Med. 2011 Nov;41(11):1006-13. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.